Search

Your search keyword '"Altenstein Slawek"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Altenstein Slawek" Remove constraint Author: "Altenstein Slawek"
118 results on '"Altenstein Slawek"'

Search Results

1. Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia

2. Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

3. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

4. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study

5. Exploring the ATN classification system using brain morphology

6. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: Evaluation in Alzheimer's disease

7. Linking early-life bilingualism and cognitive advantage in older adulthood

8. Single-value brain activity scores reflect both severity and risk across the Alzheimer’s continuum

9. Machine Learning–Based Perivascular Space Volumetry in Alzheimer Disease

10. Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology

11. Plasma amyloid beta X‐42/X‐40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.

12. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.

13. Single-value fMRI scores reflect both stage and risk across the Alzheimer's disease continuum

14. Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline

15. Machine learning‐based classification of Alzheimer's disease and its at‐risk states using personality traits, anxiety, and depression

16. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

17. Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment

18. Perivascular space enlargement accelerates with hypertension, white matter hyperintensities, chronic inflammation, and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study

19. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume

20. A 6-items Questionnaire (6-QMD) captures a Mediterranean like dietary pattern and is associated with memory performance and hippocampal volume in elderly and persons at risk for Alzheimer’s disease

21. Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts

22. Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts

23. Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease

24. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study

25. Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve

26. A Cognitive Reserve Network That Moderates the Relationship Between Alzheimer’s Disease Pathology and Cognition

27. Machine learning-based classification of Alzheimer’s disease and its at-risk states using personality traits, anxiety, and depression

28. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: A cross-sectional study

29. Musical Activity During Life Is Associated With Multi-Domain Cognitive and Brain Benefits in Older Adults

30. Exploring the ATN classification system using Brain Morphology

31. Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

32. Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease

33. Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.

34. Individualized Gaussian Process-based Prediction of Memory Performance and Biomarker Status in Ageing and Alzheimer's disease

35. Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease

36. Additional file 5 of Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

37. Additional file 2 of Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

38. Additional file 6 of Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

39. Additional file 3 of Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

40. Additional file 1 of Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

41. Additional file 4 of Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

42. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer’s disease spectrum

43. Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer’s disease spectrum

44. Memorability of photographs in subjective cognitive decline and mild cognitive impairment: implications for cognitive assessment

45. Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age

46. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study.

47. Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.

48. Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts.

49. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.

50. Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology.

Catalog

Books, media, physical & digital resources